Business Description
Shin Nippon Biomedical Laboratories Ltd
ISIN : JP3379950003
Description
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.49 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.88 | |||||
| Debt-to-EBITDA | 3.71 | |||||
| Interest Coverage | 30.41 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.13 | |||||
| Beneish M-Score | -1.97 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 19.9 | |||||
| 3-Year EBITDA Growth Rate | 28 | |||||
| 3-Year EPS without NRI Growth Rate | 46.1 | |||||
| 3-Year Book Growth Rate | 17.2 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 81.46 | |||||
| 9-Day RSI | 68.03 | |||||
| 14-Day RSI | 58.91 | |||||
| 6-1 Month Momentum % | -19.34 | |||||
| 12-1 Month Momentum % | -47.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | |||||
| Quick Ratio | 0.96 | |||||
| Cash Ratio | 0.58 | |||||
| Days Inventory | 261.27 | |||||
| Days Sales Outstanding | 64.89 | |||||
| Days Payable | 14.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.42 | |||||
| Dividend Payout Ratio | 0.38 | |||||
| 3-Year Dividend Growth Rate | 115.4 | |||||
| Forward Dividend Yield % | 3.42 | |||||
| 5-Year Yield-on-Cost % | 3.42 | |||||
| Shareholder Yield % | -9.61 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 52.19 | |||||
| Operating Margin % | 14.97 | |||||
| Net Margin % | 20.61 | |||||
| FCF Margin % | -3.77 | |||||
| ROE % | 19.27 | |||||
| ROA % | 8.64 | |||||
| ROIC % | 5.6 | |||||
| ROC (Joel Greenblatt) % | 32.16 | |||||
| ROCE % | 16.75 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 11.61 | |||||
| PE Ratio without NRI | 11.39 | |||||
| Shiller PE Ratio | 26.96 | |||||
| PEG Ratio | 0.15 | |||||
| PS Ratio | 2.39 | |||||
| PB Ratio | 2.12 | |||||
| Price-to-Tangible-Book | 2.29 | |||||
| Price-to-Operating-Cash-Flow | 15.96 | |||||
| EV-to-EBIT | 10.78 | |||||
| EV-to-EBITDA | 10.78 | |||||
| EV-to-Revenue | 2.91 | |||||
| EV-to-FCF | -81.53 | |||||
| Price-to-Projected-FCF | 1.59 | |||||
| Price-to-Median-PS-Value | 1.28 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.46 | |||||
| Price-to-Graham-Number | 1.08 | |||||
| Earnings Yield (Greenblatt) % | 9.28 | |||||
| FCF Yield % | -1.49 | |||||
| Forward Rate of Return (Yacktman) % | 22.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shin Nippon Biomedical Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 176.212 | ||
| EPS (TTM) (€) | 0.871 | ||
| Beta | -0.15 | ||
| Volatility % | 23.21 | ||
| 14-Day RSI | 58.91 | ||
| 14-Day ATR (€) | 0.107868 | ||
| 20-Day SMA (€) | 8.7075 | ||
| 12-1 Month Momentum % | -47.55 | ||
| 52-Week Range (€) | 8.4 - 16.7 | ||
| Shares Outstanding (Mil) | 41.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shin Nippon Biomedical Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shin Nippon Biomedical Laboratories Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shin Nippon Biomedical Laboratories Ltd Frequently Asked Questions
What is Shin Nippon Biomedical Laboratories Ltd(FRA:YB3)'s stock price today?
The current price of FRA:YB3 is €9.10. The 52 week high of FRA:YB3 is €16.70 and 52 week low is €8.40.
When is next earnings date of Shin Nippon Biomedical Laboratories Ltd(FRA:YB3)?
The next earnings date of Shin Nippon Biomedical Laboratories Ltd(FRA:YB3) is .
Does Shin Nippon Biomedical Laboratories Ltd(FRA:YB3) pay dividends? If so, how much?
The Dividend Yield %  of Shin Nippon Biomedical Laboratories Ltd(FRA:YB3) is 3.42% (As of Today), Highest Dividend Payout Ratio of Shin Nippon Biomedical Laboratories Ltd(FRA:YB3) was 0.38. The lowest was 0.06. And the median was 0.09. The  Forward Dividend Yield % of Shin Nippon Biomedical Laboratories Ltd(FRA:YB3) is 3.42%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers